Contracting models and SLAs for outsourced RI services Contracting models and SLAs for outsourced RI services In the evolving landscape of pharmaceutical and biotech industries, outsourcing regulatory intelligence (RI) has become a strategic approach to optimize operational efficiencies and facilitate effective regulatory compliance. This article serves as a comprehensive guide for regulatory professionals, focusing on various contractual models, service level agreements (SLAs), and the implications of outsourcing versus in-house regulatory intelligence. Context The regulatory landscape across the US, UK, and EU presents a unique set of challenges for pharmaceutical and biotech companies. As the complexity of regulatory requirements increases, many…

Governance structures for managing external RI providers Governance structures for managing external RI providers Regulatory Affairs Context As pharmaceutical and biotechnological companies increasingly rely on external partners for regulatory intelligence (RI), establishing robust governance structures becomes essential. This shift towards outsourcing regulatory intelligence instead of maintaining in-house capabilities can lead to cost efficiency but also introduces risks that need to be managed meticulously. Understanding the regulations, guidelines, and standards from the FDA, EMA, and MHRA is critical for frameworks that manage this dynamic effectively. Legal and Regulatory Basis The legal and regulatory framework surrounding the outsourcing of regulatory intelligence is…

Talent strategy for building high impact internal RI capabilities Talent strategy for building high impact internal RI capabilities The evolution of regulatory affairs in the pharmaceutical and biotechnology sectors necessitates a strategic approach to the deployment of regulatory intelligence (RI). With the growing complexity of global regulatory frameworks, organizations are increasingly challenged to optimize their regulatory intelligence operations. This article serves as a comprehensive guide for regulatory affairs professionals, particularly in understanding the balance between outsourcing regulatory intelligence and developing robust in-house capabilities. Context Regulatory intelligence is integral to successfully navigating the regulatory landscape. It encompasses the collection, analysis, and…

Decision frameworks to revisit RI outsourcing every few years Decision frameworks to revisit RI outsourcing every few years In the dynamic world of pharmaceutical and biotech industries, the decision to outsource regulatory intelligence (RI) or maintain in-house capabilities is a pivotal one. This decision impacts not only compliance and governance but also the overall cost and return on investment (ROI) for organizations. This article provides a comprehensive regulatory explainer manual detailing the frameworks and considerations necessary for evaluating outsourcing versus in-house regulatory intelligence. Context of Regulatory Intelligence in Pharmaceutical and Biotech Industries Regulatory intelligence encompasses the systematic collection and analysis…

Global footprint considerations for outsourced RI support Global footprint considerations for outsourced RI support Outsourcing regulatory intelligence (RI) has emerged as a significant strategy for pharmaceutical and biotech companies aiming to navigate the complex landscape of regulatory compliance effectively. This article serves as a comprehensive regulatory explainer manual for understanding the implications of outsourcing regulatory intelligence versus maintaining an in-house function, focusing on both cost and ROI analysis, governance structures, and hybrid model considerations in the context of US, EU, and UK regulations. Context The role of regulatory affairs (RA) is pivotal in ensuring that pharmaceuticals and biologics meet all…